Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC).
biomarkers
breast cancer
neoadjuvant therapy
pathological response
Journal
Pathologica
ISSN: 1591-951X
Titre abrégé: Pathologica
Pays: Italy
ID NLM: 0401123
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
17
01
2022
accepted:
21
01
2022
pubmed:
14
4
2022
medline:
30
4
2022
entrez:
13
4
2022
Statut:
ppublish
Résumé
Neoadjuvant therapy (NAT) in breast cancer is administered to downstage the tumor, de-escalate surgery, and provide prognostic information that can be used to tailor subsequent adjuvant therapy. In this respect, the pathological evaluation of both pre-NAT biopsies and post-NAT surgical specimens is crucial to precisely assess the treatment response. With the increasing possibilities of NAT protocols and the rising number of eligible patients, it has become extremely important to standardize the pathological response assessment. Here, we provide an update on the recommendations of the Italian Group for the Study of Breast Pathology - the Italian Society of Pathology (GIPaM-SIAPeC) for the analysis of breast cancer samples before and after NAT.
Identifiants
pubmed: 35414722
doi: 10.32074/1591-951X-747
pmc: PMC9248246
doi:
Types de publication
Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
104-110Informations de copyright
Copyright © 2022 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.
Références
PLoS One. 2014 Sep 11;9(9):e105316
pubmed: 25210779
Histol Histopathol. 2021 Dec;36(12):1235-1245
pubmed: 34585734
J Clin Oncol. 2016 Apr 1;34(10):1072-8
pubmed: 26811528
Lancet Oncol. 2022 Jan;23(1):149-160
pubmed: 34902335
Eur J Surg Oncol. 2016 Jul;42(7):919-25
pubmed: 27005805
Ann Oncol. 2015 Jul;26(7):1280-91
pubmed: 26019189
Ann Oncol. 2017 Aug 1;28(8):1700-1712
pubmed: 28838210
Breast Cancer. 2018 Mar;25(2):191-197
pubmed: 29094254
Front Oncol. 2020 Nov 18;10:620574
pubmed: 33312961
BMC Cancer. 2018 Sep 29;18(1):935
pubmed: 30268112
Breast Cancer Res Treat. 2020 Jun;181(2):249-254
pubmed: 32277375
Oncology (Williston Park). 2019 Jan 17;33(1):19-25
pubmed: 30731014
Breast Cancer Res. 2020 Jul 20;22(1):77
pubmed: 32690069
Breast Cancer Res Treat. 2018 Jun;169(2):295-304
pubmed: 29374852
Breast. 2019 Apr;44:15-23
pubmed: 30580170
Ann Surg Oncol. 2015 May;22(5):1441-6
pubmed: 25727556
J Clin Oncol. 2015 Jan 20;33(3):258-64
pubmed: 25452445
Fac Rev. 2021 Jan 04;10:2
pubmed: 33659921
Front Oncol. 2020 Jun 16;10:864
pubmed: 32612947
PLoS One. 2016 Sep 08;11(9):e0162605
pubmed: 27606623
Semin Cancer Biol. 2018 Oct;52(Pt 2):16-25
pubmed: 29024776
Diagnostics (Basel). 2021 Feb 18;11(2):
pubmed: 33670699
Ann Surg Oncol. 2019 Oct;26(10):3040-3045
pubmed: 31342394
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Breast Cancer Res. 2010;12(4):207
pubmed: 20804570
Tumori. 2022 Jun;108(3):196-203
pubmed: 34918596
J Clin Oncol. 2020 Apr 20;38(12):1346-1366
pubmed: 31928404
Recent Results Cancer Res. 2015;199:1-13
pubmed: 25636424
Breast Cancer Res Treat. 2022 Feb;191(3):589-598
pubmed: 34878635
Eur J Cancer. 2017 Feb;72:244-250
pubmed: 28064097
Breast. 2013 Aug;22 Suppl 2:S88-91
pubmed: 24074800
Pathologica. 2020 Mar;112(1):25-41
pubmed: 32202537
Breast. 2022 Mar;62 Suppl 1:S25-S28
pubmed: 34810049
Ann Surg Oncol. 2014 Sep;21(9):2897-903
pubmed: 24777858
Front Oncol. 2020 Feb 19;10:173
pubmed: 32140450
J Clin Oncol. 2021 May 1;39(13):1485-1505
pubmed: 33507815
Eur J Surg Oncol. 2021 Feb;47(2):240-244
pubmed: 32962889
Breast J. 2019 Mar;25(2):273-277
pubmed: 30734420
Breast Cancer Res Treat. 2021 Apr;186(3):607-615
pubmed: 33611665
Ann Ital Chir. 2018;89:290
pubmed: 30352955
Anticancer Agents Med Chem. 2022;22(4):801-810
pubmed: 34151769
Curr Breast Cancer Rep. 2021;13(4):241-246
pubmed: 34804375
J Pathol Transl Med. 2017 Jan;51(1):69-78
pubmed: 28013533
JCO Glob Oncol. 2020 Feb;6:238-241
pubmed: 32073911
Clin Oncol (R Coll Radiol). 2019 Sep;31(9):664-668
pubmed: 31229382
PLoS One. 2020 Jun 5;15(6):e0234173
pubmed: 32502222
Memo. 2018;11(3):199-203
pubmed: 30220926
Surg Clin North Am. 2013 Apr;93(2):493-9
pubmed: 23464698
Nat Rev Clin Oncol. 2016 Aug;13(8):487-503
pubmed: 26856744
Histopathology. 2015 Sep;67(3):279-93
pubmed: 25585651
Front Oncol. 2021 Aug 24;11:723693
pubmed: 34504801
Ann Surg Oncol. 2018 Jun;25(6):1488-1494
pubmed: 29572705